FITB
Fifth Third Bancorp
FITB's outlook is improving despite an expensive valuation.
MS
Morgan Stanley
MS has the edge over FITB overall, supported by stronger valuation and stronger fundamentals.
FITB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
FITB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FITB.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
FITB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.1x | $26.42 | -51% |
| Forward | 11x | $53.90 | — |
| Fair | 12x | $34.61 | -36% |
| Expensive | 15x | $42.99 | -20% |
| Current | 19x | $53.90 | — |
Historical ranges are pointers, not guarantees.
FITB's PE is in its expensive range at 19x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over FITB in the historical PE scenario, which offers more potential upside but is not a forecast.
FITB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FITB, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
FITB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.73 | +63% |
| Q3 2026 | $2.91 | -13% |
| Q2 2026 | $2.92 | -9.3% |
| Q1 2026 | $2.97 | -5.7% |
| Q4 2025 | $3.53 | +12% |
| Q3 2025 | $3.35 | +12% |
| Q2 2025 | $3.22 | +2.9% |
| Q1 2025 | $3.15 | +0.3% |
| Q4 2024 | $3.14 | -2.5% |
FITB earned $2.91 per share over the past year, down 13% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over FITB on earnings, with more consistent year-over-year improvement.
FITB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +43% |
| Q2 2026 | $3.3B | +46% |
| Q1 2026 | $2.8B | +33% |
| Q4 2025 | $2.3B | +7.8% |
| Q3 2025 | $2.3B | +7.9% |
| Q2 2025 | $2.2B | +7.8% |
| Q1 2025 | $2.1B | +1.8% |
| Q4 2024 | $2.2B | +0.5% |
FITB's revenue has grown year over year for eight quarters in a row: $3.3B last quarter, up 43% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -2.6 points |
| Q2 2026 | 32% | -4.4 points |
| Q1 2026 | 7.3% | -23 points |
| Q4 2025 | 39% | +3.8 points |
| Q3 2025 | 36% | +2.2 points |
| Q2 2025 | 36% | -0.7 points |
| Q1 2025 | 31% | -0.8 points |
| Q4 2024 | 35% | +5.2 points |
FITB has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over FITB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
FITB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $651M | -27% |
| Q2 2026 | $2.6B | +125% |
| Q1 2026 | -$1.3B | -212% |
| Q4 2025 | $765M | +$1B |
| Q3 2025 | $886M | -49% |
| Q2 2025 | $1.2B | +98% |
| Q1 2025 | $1.1B | +248% |
| Q4 2024 | -$246M | -113% |
FITB has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
FITB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +1.1M shares |
| 1 year | +36% | +243M shares |
| 3 years | +34% | +231M shares |
| 5 years | +28% | +199M shares |
| Available history | +27% | +197M shares |
FITB has 917M diluted shares, up 36% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $300M |
| Q2 2025 | — |
| Q1 2025 | $225M |
| Q4 2024 | $300M |
FITB hasn't bought back shares in the past year.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over FITB on shareholder dilution, with a more favorable share count trend.
FITB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.5x | Elevated |
| Q2 2026 | 4.9x | High |
| Q1 2026 | 4.7x | High |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 3.3x | Elevated |
FITB has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
FITB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.6 | Neutral |
| Stochastic | 47.3 | Neutral |
FITB's weekly RSI is 54 (neutral) and its Stochastic is 47 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
FITB PE vs Financial Services Sector
| Metric | FITB | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 42% above |
| PE % | 94 | 63 | 31 pts above |
FITB is trading at 19x earnings, a 42% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over FITB on valuation relative to its sector.
FITB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.2 | 3.2% above |
| 20 week MA | $54.6 | 1.2% below |
| 50 week MA | $51.5 | 4.6% above |
| 100 week MA | $46.5 | 16% above |
| 200 week MA | $40.1 | 34% above |
FITB has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
FITB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.9 | $27.6 | -11% |
| 2021 | $27.6 | $43.1 | +56% |
| 2022 | $43.1 | $32.4 | -25% |
| 2023 | $32.4 | $34.5 | +6.4% |
| 2024 | $34.5 | $42.9 | +24% |
| 2025 | $42.9 | $48.4 | +13% |
| 2026 YTD | $48.4 | $53.9 | +11% |
FITB has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.